The American journal of nursing
-
The continuing impact of the pandemic on pregnant women and obstetric care.
-
Advances against COVID-19 offer hope, but work remains before we can fully move on.
-
Baloxavir marboxil (Xofluza), an antiviral flu treatment, has now been approved to prevent influenza. Patients should avoid taking calcium, aluminum, or magnesium products while receiving baloxavir as this will lead to a loss of antiviral efficacy.
-
According to this study: The antiviral remdesivir is superior to placebo in the treatment of patients hospitalized with COVID-19. A variety of therapeutic approaches are needed to continue to improve outcomes in COVID-19 patients.
-
Among the most common causes of U. S. adult hospitalizations, pneumonia accounted for nearly 50,000 deaths in the United States in 2017. ⋯ The article also details key similarities and differences between the new 2019 guideline jointly developed by the American Thoracic Society and the Infectious Diseases Society of America on diagnosis and treatment of adults with community-acquired pneumonia and their earlier 2007 guideline. One crucial difference is the growing recognition that the etiology of pneumonia is changing, necessitating the abandonment of prior categorizations of pneumonia type when determining antibiotic coverage in favor of reliance on local epidemiology and validated risk factors for antimicrobial resistance.